Jazz Pharmaceuticals plc buy The Goldman Sachs Group, Inc.
Start price
29.08.25
/
50%
€109.20
Target price
29.08.26
€158.67
Performance (%)
58.33%
Price
17.04.26
€172.90
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc has seen massive gains of 58.33%. This prediction currently runs until 29.08.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 4.440% | 4.440% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $162.00 to $185.00. They now have a "buy" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€98.06
05.06.24
05.06.24
€155.23
05.06.25
05.06.25
-1.35%
06.06.25
06.06.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€137.36
03.03.23
03.03.23
€199.47
03.03.24
03.03.24
-19.63%
04.03.24
04.03.24